In the rapidly evolving world of Artificial Intelligence (AI) and Machine Learning (ML), staying ahead of the curve is crucial, especially in sectors as critical as healthcare. The Food and Drug Administration (FDA) has recognized this need and is actively guiding the integration of these technologies into healthcare through its Total Product Lifecycle (TPLC) approach. Today’s blog post is a look at some of the actionable steps Product Managers can take when incorporating AI/ML into digital health, biopharma, or medical device products in order to speed the product to market..
Our journey begins with a visual representation of FDA’s Good Machine Learning Practices, a comprehensive guide to understanding the various facets of implementing AI/ML solutions in healthcare and what bar the regulator is setting in order sell your product. From the foundational aspects of data quality to the complexities of real-world performance monitoring, the mind map meticulously details each step in the lifecycle of AI/ML products under the FDA’s oversight.
The TPLC approach by the FDA doesn't just focus on the initial stages of product development and market entry; it encompasses the entire spectrum of a product's life. It includes pre-market activities, rigorous post-market surveillance, and continuous updates in response to emerging data and technological advancements.
What is a product manager who is incorporating AI/ML technologies into digital health, biopharma, or medical device products to consider when looking at potential opportunities?
Obviously there are a boatload of other security, privacy, regulatory, and engineering concerns to navigate, but by keeping Product focused on providing a high quality experience to the end user by providing an accurate result, you can accelerate your time to market.